Toggle navigation
Home
Search
Services
Blog
Contact
About
Cardiovascular Molecular Prognostic Kits
Bentley, Kevin L.
Genaissance Pharmaceuticals, Inc., New Haven, CT, United States
Search 4 grants from Kevin Bentley
Search grants from Genaissance Pharmaceuticals, Inc.
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Data and Safety Monitoring System
Mechanism of Translation Elongation Factor 2 Inhibition by Bacterial Toxins
Human Embryonic Stem Cell Derived Cardiac Progenitors
Parkinson's Disease, Psychophysiology, and the Amygdala
CAREER: Nanoelectronic Microfluidic Biochip for Ultrasensitive Detection of Selective Protein Biomarkers
Recently added grants:
Conformal Total Body and Marrow Irradiation for Leukemia
CRISPR inhibition as an alternate for Cre-loxP
Modulating innate immune cells in the tumor microenvironment of pancreas cancer to enhance anti-tumor immunity
Sequence-specific Hybridization Capture for Discovery of Proteoform?lncRNA Interactions in Prostate Cancer
Randomized Controlled Trial of Resistant Starch to Reduce Colon Cancer Risk in Alaska Native People
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Small Business Innovation Research Grants (SBIR) - Phase II (R44)
Project #
9R44HL059114-02
Application #
2423742
Study Section
Special Emphasis Panel (ZRG2-SSS-Y (15))
Project Start
1997-08-29
Project End
1999-07-31
Budget Start
1997-08-29
Budget End
1998-07-31
Support Year
2
Fiscal Year
1997
Total Cost
Indirect Cost
Institution
Name
Genaissance Pharmaceuticals, Inc.
Department
Type
DUNS #
City
New Haven
State
CT
Country
United States
Zip Code
06511
Related projects
NIH 1998
R44 HL
Cardiovascular Molecular Prognostic Kits
Bentley, Kevin L. / Genaissance Pharmaceuticals, Inc.
NIH 1997
R44 HL
Cardiovascular Molecular Prognostic Kits
Bentley, Kevin L. / Genaissance Pharmaceuticals, Inc.
Comments
Be the first to comment on Kevin Bentley's grant